Compounded semaglutide: how it works, what it costs and who it fits

Compounded semaglutide is semaglutide, a GLP-1 medicine, prepared with vitamin B12 by a state-licensed 503A pharmacy for one patient’s prescription. It is a weekly injection. It is compounded and not FDA-approved, and it is not Wegovy® or Ozempic®. Through VevaMD a board-certified physician decides whether it fits you, and one monthly price covers the physician, the medication and shipping.

Compounded, not FDA-approvedWeekly injection, with vitamin B12

See if compounded semaglutide fits me →

A board-certified, US-licensed physician reviews every intake.

What Compounded semaglutide costs at VevaMD

  • As low as $199/mo. Includes physician review, medication and shipping. Same price at every dose.
  • No membership fee for compounded GLP-1; brand Wegovy® and Zepbound® have a VevaMD membership, and you pay the manufacturer for the medication. No contract; cancel anytime on My VevaMD. Full refund if not prescribed. HSA & FSA eligible. Labs, if your physician orders them, are billed separately and shown before you pay.
  • You see your price before you pay. Full refund if not prescribed.

Compounded medications are prepared by state-licensed pharmacies for individual patients. They are not FDA-approved and have not been reviewed by FDA for safety, effectiveness or quality.

What compounded semaglutide is

Semaglutide is a GLP-1 receptor agonist: a medicine that acts on the receptor for GLP-1, a hormone your gut releases after you eat. Compounded semaglutide is that ingredient prepared by a licensed pharmacist for one person’s prescription, rather than made by a drug company as a finished product [1]. The compounded semaglutide prescribed through VevaMD comes with vitamin B12 in the same vial, and it is prepared by NewLife Rx, a state-licensed 503A pharmacy, only after a physician writes the prescription.

Three facts define it. It is compounded and not FDA-approved: the FDA does not review compounded drugs for safety, effectiveness or quality before they are sold [1]. It is not a generic: a generic drug is FDA-approved and has to establish therapeutic equivalence with its brand, and a compounded drug is not approved at all [1]. It is not Wegovy® or Ozempic®, the semaglutide products Novo Nordisk makes, so this page uses no numbers from their trials.

How VevaMD prescribes it

The FDA lists red flags for buying a GLP-1 online: no screening by a licensed doctor, no doctor to answer questions once the medicine arrives, a pharmacy you cannot check, and claims that a compounded drug matches an approved one [2]. VevaMD is built the other way around.

  • A physician decides. A board-certified, US-licensed physician reviews your intake, can message you, order labs or ask for a video visit, and can say no. If nothing is prescribed, your first payment is refunded in full.
  • A named, state-licensed pharmacy. The FDA notes that people who buy compounded drugs online often do not know who compounded them [1]. Yours is prepared by NewLife Rx, a 503A pharmacy overseen by its state board of pharmacy, and shipped to your door.
  • One price, shown before you pay. As low as $199/mo, covering the physician, the medication and shipping, the same at every dose, with no membership fee on compounded plans.
  • Care that continues. Your physician manages the plan as the amount goes up and checks in over time, and the VevaMD team answers questions about your order by phone or email.
  • Every option in one place. If an FDA-approved brand is the better fit, the same intake can lead to Wegovy® or Zepbound®.

Who it may be for, and who it is not for

May be for

  • Adults with a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure or type 2 diabetes: the group NIDDK describes for weight-management medicines [3]
  • People who have worked on eating and activity and want a medicine alongside it; the Endocrine Society calls medicines for chronic weight management useful adjuncts to lifestyle change [4]
  • People comfortable giving themselves a small weekly injection under the skin
  • People who want one predictable monthly price that does not climb as the amount goes up

Not for

  • Anyone with a personal or family history of medullary thyroid carcinoma (MTC), or with multiple endocrine neoplasia syndrome type 2 (MEN 2) [5]
  • Anyone who is pregnant or breastfeeding; the Wegovy® label advises stopping semaglutide at least 2 months before a planned pregnancy [5]
  • Anyone who has had a serious allergic reaction to semaglutide [5]
  • Anyone already on another GLP-1 medicine, such as Ozempic® or Mounjaro®; the label advises against combining them [5]
  • People with severe gastroparesis [5]
  • People with type 1 diabetes

How semaglutide works

Your gut releases GLP-1 after a meal as a fullness signal, but it lasts only minutes. Semaglutide is built to resemble it and to last a week. The Wegovy® label describes semaglutide acting on GLP-1 receptors in the brain areas that regulate appetite and calorie intake, and slowing how fast the stomach empties [5]. NIDDK puts the effect in plain terms: some weight-management medicines help you feel less hungry, or full sooner [3].

Your physician starts low and raises the amount step by step over several weeks. That keeps stomach side effects down, and the Obesity Medicine Association notes that many patients start at a lower dose and work up [6]. You get the plan in writing, and the price does not change as the amount rises.

The medication comes as a liquid in a small multi-dose vial. You draw each weekly amount into a new, sterile syringe and inject it under the skin. Two FDA handling points apply to any vial like it: injectable GLP-1 medicines need refrigeration, so do not use one that arrives warm, and a multi-dose vial is discarded 28 days after the first use even if some is left [2].

What to expect over time

  1. Before you startA private online intake about your weight, your health history and every medicine you take. A physician reviews it and decides whether to prescribe.
  2. The first weeksYou begin at the lowest amount. Nausea, early fullness and changes in bowel habits are most likely now, while your body adjusts [6].
  3. The first monthsYour physician raises the amount in steps as you tolerate it. Each step is a check-in on how you feel, your side effects, and whether to hold or go up.
  4. At the full amountNIDDK’s rule of thumb for any weight-management medicine: after 12 weeks on the full dose, your health care professional looks at whether you have lost at least 5% of your starting weight and decides whether to continue or change course [3].
  5. Long termObesity is a chronic disease, and NIDDK says most people regain some weight after they stop a weight-management medicine [3]. Your physician keeps managing the plan for as long as you stay on it.

Side effects and risks

Compounded semaglutide has no FDA label of its own. The risks below are the ones the FDA-approved Wegovy® label lists for semaglutide made by Novo Nordisk, and your physician reviews them with you.

  • Most common: nausea, diarrhea, vomiting, constipation and stomach pain, most often while the amount is going up [5].
  • Serious but less common: inflammation of the pancreas, gallbladder disease, kidney injury from dehydration, severe stomach side effects, serious allergic reactions, a faster resting heart rate, low blood sugar when taken with insulin or a sulfonylurea, and worsening eye disease in people with diabetic retinopathy [5].
  • Before surgery or sedation: semaglutide slows stomach emptying, and rare cases of food entering the lungs under anesthesia have been reported with GLP-1 medicines, so tell anyone doing a procedure that you take it [5].
  • Pregnancy: it may harm an unborn baby, so it is stopped when a pregnancy is recognized [5].

One FDA point is specific to vials: the agency has received reports of dosing errors with compounded semaglutide, from amounts measured incorrectly, and asks patients to confirm with their prescriber or pharmacy exactly how to measure each dose [2]. Your physician’s written plan is there for that.

What the FDA says about compounded semaglutide

Semaglutide injection was on the FDA’s shortage list from 2022. On February 21, 2025 the FDA declared that shortage resolved, so pharmacies can no longer rely on it to compound semaglutide [7]. A state-licensed 503A pharmacy compounds it for an individual patient’s prescription, under its state board of pharmacy [1]. On April 30, 2026 the FDA proposed leaving semaglutide off the list of bulk ingredients that large outsourcing facilities, known as 503B, may use; that proposal is about outsourcing facilities, not 503A pharmacies [8].

VevaMD follows the FDA’s rules for how telehealth companies describe a compounded GLP-1: never calling it FDA-approved, never claiming trials show it matches a brand, and naming the pharmacy that makes it [9]. (The FDA’s general position is that compounded drugs are for patients whose needs an FDA-approved drug cannot meet [1]; Wegovy® is available through the same intake.) Read more about compounded medications.

Compared with the other GLP-1 options

Every GLP-1 option at VevaMD starts from the same intake, and your physician recommends one. Compounded tirzepatide acts on a second gut-hormone receptor as well as GLP-1. Wegovy® and Zepbound® are the FDA-approved brands, through a membership.

The four GLP-1 options at VevaMD
FDA statusHow it is takenHow you pay at VevaMDMain trade-offs
Compounded semaglutideCompounded, not FDA-approvedWeekly injection from a vial, with vitamin B12One monthly price, as low as $199/mo: physician, medication and shipping. No membership feeThe lowest monthly price, the same at every dose; you draw each dose with a syringe
Compounded tirzepatideCompounded, not FDA-approvedWeekly injection from a vial, with vitamin B12One monthly price, as low as $299/mo: physician, medication and shipping. No membership feeActs on two gut-hormone receptors, GLP-1 and GIP; the same price at every dose; you draw each dose with a syringe
Wegovy®FDA-approved brandWeekly prefilled pen, or a daily tabletA $149/mo VevaMD membership, plus the self-pay price paid to Novo Nordisk ($348–$498/mo in total for the pen)Approved for weight and to lower heart risk in adults with heart disease; pen or pill; two separate charges
Zepbound®FDA-approved brandWeekly prefilled penA $149/mo VevaMD membership, plus the self-pay price paid to Eli Lilly ($448–$598/mo in total)Approved for weight and for moderate to severe sleep apnea with obesity; prefilled pen; two separate charges

Weight gain in perimenopause and menopause

Gaining weight in midlife is one of the most common concerns women bring to a physician. The Menopause Society says aging is the main driver, while the fall in estrogen at menopause moves fat toward the abdomen, where it carries more heart and metabolic risk. Hot flashes and broken sleep make healthy habits harder to keep [10].

Common questions

Why does compounded semaglutide come with vitamin B12?

The pharmacy prepares semaglutide and vitamin B12 together in one vial, so B12 is part of the prescription you receive. VevaMD does not claim that B12 changes how semaglutide works. Tell your physician if you already take B12 or have been told to avoid it.

Can I still get compounded semaglutide in 2026?

Yes, if a physician prescribes it. The FDA declared the semaglutide shortage over on February 21, 2025. Through VevaMD it is prepared by NewLife Rx, a state-licensed 503A pharmacy, for your prescription; the FDA’s 2026 proposal on bulk ingredients covers 503B outsourcing facilities, not 503A pharmacies.

How should I store a vial of compounded semaglutide?

Keep it in the refrigerator and do not use a vial that arrives warm. The FDA recommends discarding a multi-dose vial 28 days after the first use, even if some is left, and using a new sterile needle and syringe for every injection.

Does the price change when my dose goes up?

No. Compounded semaglutide through VevaMD is one monthly price at every dose, and it covers the physician, the medication and shipping. You see the exact price before you pay.

What happens if I stop taking semaglutide?

NIDDK says most people regain some weight after they stop a weight-management medicine, because obesity is a chronic disease. Talk with your VevaMD physician first: they can plan the change and what to keep doing.

Can I switch from compounded semaglutide to Wegovy later?

Yes. Your VevaMD physician can move you to Wegovy®, the FDA-approved semaglutide pen or pill, through a VevaMD membership, and you then pay Novo Nordisk for the medication. The same physician manages the change.

A physician decides what fits you

See if compounded semaglutide fits me →

One private online intake covers every GLP-1 option. You see your price before you pay, and your first payment is refunded in full if nothing is prescribed.

Last updated . Content standards

Clinical care is provided by board-certified, US-licensed physicians. VevaMD Inc is a technology and marketing storefront only — not a medical provider or a pharmacy. Medications are dispensed by licensed U.S. partner pharmacies after a valid prescription. Compounded medications are prepared by state-licensed pharmacies for individual patients. They are not FDA-approved and have not been reviewed by FDA for safety, effectiveness or quality. Wegovy®, Ozempic®, Zepbound® and Mounjaro® are trademarks of their owners. VevaMD is not affiliated with Novo Nordisk or Eli Lilly. This page is general information, not medical advice. A prescription is not guaranteed, and outcomes differ from person to person. Report a side effect to FDA MedWatch.